Cognition Therapeutics
CGTX
CGTX
47 hedge funds and large institutions have $12.9M invested in Cognition Therapeutics in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Holders
47
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.18M | |
| 2 | +$910K | |
| 3 | +$875K | |
| 4 |
CCM
Corsair Capital Management
New York
|
+$519K |
| 5 |
HWM
Hohimer Wealth Management
Seattle,
Washington
|
+$410K |
Top Sellers
| 1 | -$4.08M | |
| 2 | -$941K | |
| 3 | -$258K | |
| 4 |
Mercer Global Advisors
Denver,
Colorado
|
-$108K |
| 5 |
Morgan Stanley
New York
|
-$74.1K |